Vuno뷰노
338220 · KOSDAQ · ₩338220 · 뷰노
- Market cap
- ₩98B
- Enterprise value
- ₩99B
- P/E
- —
- P/B
- 2.8×
- Dividend yield
- 0.0%
- ROE
- −31.0%
- Net margin
- −36.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−75.2% from the high
₩4,235Today: ₩6,930 – ₩7,560₩28,350
Returns
- 1W+8.5%
- 1M+26.2%
- 3M−2.5%
- 6M−64.2%
- YTD−68.5%
- 1Y−69.3%
- Volume today
- 852,456
- 1.6× the 20-day average
- Traded today
- ₩6.2B
- Listed shares
- 14,001,823
- EPS (12 months)
- −₩789
- Earnings yield −11.2%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
−8.5% on Oct 27, 2026. Trading value 1.6× its normal.
- • Foreign investors bought a net ₩171M that day
We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.
Possible reasons, not certainties. Not financial advice.
Signals
Normal- BuzzNormalBuzz 50 of 100 (50 is a normal day for this stock).
- MomentumFlat36.5% over the last month; the price is below its 20-day average.
- News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Vuno stock overview
Vuno (뷰노, KRX: 338220) is listed on KOSDAQ, in the Software sector. VUNO is a South Korean medical software company that applies deep learning to medical data such as biosignals and medical images (X-ray, CT, MRI, fundus images) to support diagnosis, prognosis and prediction. Its shares closed at ₩7,030 on Oct 27, 2026, down 8.46% on the day, giving it a market value of ₩98B.
Key facts
- Market cap
- ₩98B
- Sector
- Software
- Latest price change
- −8.46%
- As of
- Oct 27, 2026
- Main business
- VUNO is a South Korean medical software company that applies deep learning to medical data such as biosignals and medical images (X-ray, CT, MRI, fundus images) to support diagnosis, prognosis and prediction.
Quick answers about Vuno
- What does Vuno do?
- VUNO is a South Korean medical software company that applies deep learning to medical data such as biosignals and medical images (X-ray, CT, MRI, fundus images) to support diagnosis, prognosis and prediction. Its main products include VUNO Med-DeepCARS, which estimates the 24-hour risk of cardiac arrest in hospitalized patients, HATIV P30 for ECG measurement and arrhythmia detection, and VUNO Med-Chest X-Ray and VUNO Med-Fundus AI for imaging analysis, sold mainly to hospitals, clinics and medical device makers, with growing sales to overseas markets including the United States, Europe and Asia.
- What is the market cap of Vuno?
- The market capitalisation of Vuno was ₩98B at the close on Oct 27, 2026.
- Who are the largest shareholders of Vuno?
- According to the latest official filings, the largest reported holders are Lee Ye-ha (15.59%, as of Sep 4, 2026); National Pension Service (1.75%, as of Dec 31, 2025); State Street(R) SPDR(R) S&P(R) International Small Cap ETF (0.05%, as of Jun 30, 2026).
- When is the next earnings report from Vuno?
- Korean companies rarely announce results dates in advance. Based on when Vuno filed the same report in past years, its next 3q results is expected between Nov 12, 2026 and Nov 14, 2026.
- Does the National Pension Service own Vuno?
- Yes. The National Pension Service held 1.75% of Vuno shares as of Dec 31, 2025.
Company profile
VUNO is a South Korean medical software company that applies deep learning to medical data such as biosignals and medical images (X-ray, CT, MRI, fundus images) to support diagnosis, prognosis and prediction. Its main products include VUNO Med-DeepCARS, which estimates the 24-hour risk of cardiac arrest in hospitalized patients, HATIV P30 for ECG measurement and arrhythmia detection, and VUNO Med-Chest X-Ray and VUNO Med-Fundus AI for imaging analysis, sold mainly to hospitals, clinics and medical device makers, with growing sales to overseas markets including the United States, Europe and Asia.
Written by AI from the company's latest annual report.
- Korean name
- 뷰노
- Sector
- Software
- CEO
- 이예하
- Founded
- Dec 2014
- Listed
- Feb 2021
- Listed shares
- 14,001,823
- Fiscal year ends
- Month 12
- Website
- www.vuno.co
Similar companies
- Hyundai Autoever307950 · ₩8.9T₩325,500+4.16%
- Krafton259960 · ₩8.4T₩182,500−0.54%
- NC036570 · ₩4.3T₩198,700−1.39%
- Netmarble251270 · ₩2.8T₩33,650+0.30%
- PearlAbyss263750 · ₩2.1T₩34,050−0.87%
- Shift UP462870 · ₩1.7T₩29,550+0.34%
- NHN181710 · ₩1.6T₩49,850+1.53%
- Kakao Games293490 · ₩1.3T₩11,850+5.80%
Recent filings
See all- Withdrawal of Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesOct 22, 2026
- Amended: Securities registration statementOct 15, 2026
- Amended: Rights offering (paid-in capital increase) decisionOct 15, 2026
- Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesOct 6, 2026
- Withdrawal of Trading Plan Report for Executives and Major Shareholders' Specific SecuritiesOct 6, 2026
Titles in Korean until English translations are added.
Also known as: Vuno / 뷰노 / 338220 / KRX:338220
Source: KRX statistical information